Surveillance of acutely ILL adults with respiratory viruses, including sars-COV-2
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30122C12914
- Awardee
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $11,908,904
Award facts
- Opportunity
-
- 75D30122R72091 Solicitation number
- Contract value 100% obligated
- $11,908,903.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Nashville, TN 37232, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,187,037 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $10,721,866 |
About this award
This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds understanding of disease attenuation and vaccine failures. Major subcontractors include the University of California Los Angeles, Regents of the University of Michigan, Emory University, Wake Forest University Health Sciences, and the University of Miami. They will assist VUMC with surveillance, data analysis, and other tasks to meet the CDC's goal of advancing public health through national immunization programs. No set aside designation was specified.
Quick answers
Who was awarded contract 75D30122C12914?
75D30122C12914 was awarded to Vanderbilt University Medical Center by CDC Pittsburgh (Centers for Disease Control and Prevention) on December 2, 2021.
How much is contract 75D30122C12914 worth?
The government has obligated $11,908,904 on 75D30122C12914.
Was contract 75D30122C12914 competed?
The extent of competition for 75D30122C12914 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award